Skip to main content

Table 2 Comparison of the response and relapse rate of the p190 and p210 patients

From: Distinct outcomes, ABL1 mutation profile, and transcriptome features between p190 and p210 transcripts in adult Philadelphia-positive acute lymphoblastic leukemia in the TKI era

 

p190

p210

p-value

CR1 rate (%)

90.1% (154/171)

91.0% (81/89)

0.805

CMR rate (%)

1 month

22% (29/132)

9.9% (7/71)

0.031

3 months

43.2% (54/125)

41.4% (29/70)

0.810

MMR rate (%)

1 month

37.9% (50/132)

28.2% (20/71)

0.165

3 months

66.4% (83/125)

61.4% (43/70)

0.486

Relapse rate (%)

33.1% (46/139)

29.3% (22/75)

0.573

  1. CR complete remission, CMR complete molecular remission, MMR major molecular remission
Back to article page

Experimental Hematology & Oncology

ISSN: 2162-3619

Contact us